New combo shows promise for Hard-to-Treat colorectal cancer
NCT ID NCT03711058
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study tested a combination of two drugs, copanlisib and nivolumab, in 48 adults with advanced solid tumors, specifically a type of colorectal cancer called MSS that hasn't responded to standard treatments. The goal was to see if the combination could shrink or control tumors. The study focused on safety and how well the treatment worked at 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE OR METASTATIC MICROSATELLITE STABLE (MSS) SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21231, United States
Conditions
Explore the condition pages connected to this study.